Sex difference in circulating PCSK9 and its clinical implications
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.953845
Abstract: Proprotein convertase subtilisin kexin type 9 (PCSK9) is a proprotein convertase that increases plasma low-density lipoprotein cholesterol (LDL-C) levels by triggering the degradation of LDL receptors (LDLRs). Beyond the regulation of circulating LDL-C, PCSK9 also… read more here.
Keywords: circulating pcsk9; clinical implications; difference circulating; sex difference ... See more keywords